As a leader in the North American cannabis market, TerrAscend’s expansion into New Jersey has brought much-needed relief to a thinly stretched and rapidly expanding medical cannabis program. With only 11 other Alternative Treatment Centers (ATC) currently serving over 97,500 medical cannabis patients in New Jersey, TerrAscend’s entrance into the state, with a reputation for quality products and operational integrity, is exactly what the Garden State needs right now.
TerrAscend’s vertically integrated cultivation and manufacturing facility in Boonton, and Alternative Treatment Center, The Apothecarium, in Phillipsburg, are serving an area of the state which was previously left underserved as other ATC’s placed focus towards the more populated Northeastern part of the state. This forced patients in the area to travel over an hour or more each way to obtain their medication.